Navigation Links
Life Recovery Systems Receives NIH Grant to Study Expanded Use of Its ThermoSuit System
Date:10/20/2008

Study Will Investigate Using Cooling Device to Treat Heart Attack Victims

WALDWICK, N.J., Oct. 20 /PRNewswire/ -- Life Recovery Systems has received a competitively awarded $700,000 grant from the National Institutes of Health (NIH) to conduct a clinical study to investigate the feasibility of cooling heart attack patients with its ThermoSuit(R) System, the only cooling device using cold water immersion to rapidly lower patient temperature.

The grant was awarded through the Small Business Innovation Research (SBIR) program of the National Heart, Lung and Blood Institute (NHLBI) of NIH. This is the third SBIR grant for Live Recovery Systems from NHLBI. The two previous grants totaling $1.3 million were to develop the ThermoSuit System.

Twenty patients will be enrolled in the study, which will be conducted under an Investigational Device Exemption that was previously granted to Life Recovery Systems by the Food and Drug Administration. The study is a cooperative effort between Life Recovery Systems and the Ochsner Clinic in New Orleans, a division of Ochsner Health System, a non-profit academic and healthcare delivery system with seven hospitals and more than 35 health centers in Southeast Louisiana.

The trial will explore the feasibility of cooling heart attack (ST-elevation acute myocardial infarction) patients with the ThermoSuit System before blood flow is restored to the heart. Patients will be sedated and cooled after entry into the emergency room and prior to percutaneous coronary intervention in the catheterization laboratory. It is expected that the ThermoSuit System will enable cooling of the patient to 34 degrees C after a treatment of 30 minutes or less and within the 90-minute door to balloon time requirement for treating ST-elevation acute myocardial infarction patients.

A successful result of the study will lead to a pivotal clinical study to investigate the potential for the ThermoSuit cooling treatment to reduce the severity of the heart attack. Previous research has suggested that cooling of some types of heart attack patients before coronary reperfusion could result in a significant reduction in the amount of injury the heart suffers.

The ultimate goal of these studies is to obtain FDA clearance for the use of the ThermoSuit System in treating heart attack patients. Life Recovery Systems believes that this would contribute to better outcomes for such patients and thus substantially increase the potential uses and market for its unique cooling technology.

http://www.life-recovery.com

Contact:

Judd Cohen

Cohen Communications

212-682-7838

judd@cohencom.net


'/>"/>
SOURCE Life Recovery Systems
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Surgex(TM) Becomes the First and Only BSCG (Banned Substance Control Group) Certified Product Which is Clinically Proven Effective in Sports Recovery and Performance
2. Sugammadex Trials Demonstrate Rapid Recovery from Profound Neuromuscular Blockade During General Anesthesia
3. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
4. Life Recovery Systems Receives European CE Mark Approval for Its ThermoSuit(R) System
5. Public Forum to Discuss Addiction as a Treatable Disease and Highlight National Alcohol and Drug Addiction Recovery Month
6. Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008
7. Complete Genomics and the Institute for Systems Biology Announce Partnership to Conduct the First Human Genome Population Study
8. Resurgent Health and Medical Announces That Childrens Hospitals and Clinics of Minnesota has Ordered 25 CleanTech Automated Handwashing Systems
9. Coapt Systems Launches FDA Cleared Novielle Voice (TM) for Restoration of Voice Loss
10. StemCor Systems Receives CE Mark for MarrowMiner(TM) System for Bone Marrow Collection
11. PLC Systems Defers Pivotal Study of RenalGuard(TM) in the U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical Systems ... "Company"), which develops, markets and sells medical devices and ... , signed a strategic cooperation agreement with Hongyuan Supply ... Supply Chain") on June 20, 2016, to develop Dehaier,s ... strategic cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s ...
(Date:6/24/2016)... Research and Markets has announced the ... Tests" report to their offering. ... The World Market for Companion Diagnostics covers the ... analysis in the report includes the following: ... Kits) by Region (N. America, EU, ROW), 2015-2020 , ...
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... , ... Quality metrics are proliferating in cancer care, and are derived from ... of the beholder, according to experts who offered insights and commentary in the current ... For the full issue, click here . , For the American Society of ...
(Date:6/26/2016)... ... ... blind and certified personal trainer is helping to develop a weight loss fitness plan that ... the two major problems leading the fitness industry today:, , All ... They don’t eliminate all the reasons people quit their exercise program , ...
(Date:6/25/2016)... ... ... temporary closing of Bruton Memorial Library on June 21 due to a possible lice infestation, ... aspect of head lice: the parasite’s ability to live away from a human host, and ... necessary one in the event that lice have simply gotten out of control. , As ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may suffer ... unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid ... healthy coping following a traumatic event. , Trauma sufferers tend to feel a range ...
Breaking Medicine News(10 mins):